In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic···【more】
Release date:2024-08-22Recommended:303
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as···【more】
Release date:2024-08-22Recommended:259
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that i···【more】
Release date:2024-08-22Recommended:266
Anamorelin is a drug for cancer cachexia that increases a patient's appetite···【more】
Release date:2024-08-21Recommended:327
As a selective ghrelin receptor agonist, anamolin is approved in Japan for impro···【more】
Release date:2024-08-21Recommended:248
Through its unique pharmacological effects, Anamoreline is effective in helping ···【more】
Release date:2024-08-21Recommended:233
Anamorelin helps cancer patients with dyscrasia restore the body's energy su···【more】
Release date:2024-08-21Recommended:281
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by vario···【more】
Release date:2024-08-21Recommended:307
Anamorelin is a novel ghrelin receptor agonist specifically designed for the tre···【more】
Release date:2024-08-21Recommended:376
Anamorelin is a selective oral medication that increases a patient's appetit···【more】
Release date:2024-08-21Recommended:287
Anamorelin is a ghrelin receptor agonist that is effective in improving appetite···【more】
Release date:2024-08-21Recommended:344
Anamorelin, the world's first oral drug specifically for the treatment of ca···【more】
Release date:2024-08-21Recommended:266